Allospecific T Cell Recognition of HLA-A2 Antigens: Evidence for Group-specific and Subgroup-specific Epitopes
Overview
Genetics
Affiliations
Interleukin 2-dependent alloreactive cytotoxic T cell lines, with activity predominantly directed against the HLA-A2 antigen, have been generated in vitro by stimulating blood mononuclear cells from donors nonimmune to the Epstein-Barr (EB) virus with appropriate numbers of EB virus-transformed B cells from A2-homozygous individuals. Such effector cells were tested against a panel of EB virus-transformed target cell lines all expressing the serologically defined A2 antigen but typed into "common A2" and "variant A2" subgroups on the basis of their recognition by A2-restricted EB virus-specific cytotoxic T cells. "Variant A2" responder cells cocultivated with "common A2"-bearing stimulators gave rise to effector T cell lines which recognized only the "common A2"-bearing subgroup of targets. By contrast, responder cells from A2-negative donors stimulated with "common A2"-bearing cells produced effector T cell lines in which the strong lysis of "common A2"-bearing targets was accompanied by a lower, but still significant, lysis directed against all targets within the "variant A2" subgroup. In both cases, lysis of the target cells was blocked equally well by the anti-A2-specific monoclonal antibody MA2.1 as by the monoclonal antibody W6/32 specific for HLA-A, -B, and -C determinants. This suggests that HLA-A2 molecules possess at least two distinct sets of epitopes capable of inducing alloreactive T cell cytotoxicity: first, epitopes probably associated with T cell-restricting sites, which generate subgroup-specific responses, and second, epitopes shared by all A2 molecules, and perhaps associated with serologically defined sites, which generate "pan A2" group-specific responses.
Rimando J, Slade M, Dipersio J, Westervelt P, Gao F, Liu C Blood Adv. 2018; 2(24):3590-3601.
PMID: 30563883 PMC: 6306877. DOI: 10.1182/bloodadvances.2018025437.
Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz M, Oudshoorn M Biol Blood Marrow Transplant. 2008; 14(9):1064-1071.
PMID: 18721770 PMC: 2572684. DOI: 10.1016/j.bbmt.2008.07.001.
DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1.
Mattson D, Handy D, Bradley D, Coligan J, Cowan E, Biddison W Immunogenetics. 1987; 26(3):190-2.
PMID: 3497874 DOI: 10.1007/BF00365911.
New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes.
Kennedy L, Wallace L, Madrigal J, Rickinson A, Bodmer J Immunogenetics. 1987; 26(3):155-60.
PMID: 3497873 DOI: 10.1007/BF00365905.
Murray R, Young L, Calender A, Gregory C, Rowe M, Lenoir G J Virol. 1988; 62(3):894-901.
PMID: 2828684 PMC: 253648. DOI: 10.1128/JVI.62.3.894-901.1988.